Zeinab Najafi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeinab Najafi has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ali Reza Tavasoli
Tehran University of Medical Sciences
1 shared publication Bahareh Yaghmaei
Department of Pediatric Intensive Care, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Bahram Yarali
Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Banafsheh Moradmand
Black Dog Institute, University of New South Wales, Sydney, Australia
1 shared publication- Elham Pourbakhtyaran
Tehran University of Medical Sciences
1 shared publication - Elmira Haji Esmaeil Memar
Pediatric Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 March 2023
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 26 (3) , 166-171
Neurologic Manifestations of Coronavirus Disease 2019 in Children: An Iranian Hospital-Based Study
Background: COVID-19 infection and its neurological manifestations were seen in children although less common than adults. The aim of this study was to determine the frequency of different types of neurologic findings of hospitalized children with COVID-19. ] Methods: This retrospective study was performed on hospitalized pediatric patients aged≤18 years with confirmed SARS-CoV-2 at Children’s Medical Center Hospital. Neurological manifestations were defined as the presence of any of the following symptoms: seizure, altered mental status, behavioral/personality change, ataxia, stroke, muscle weakness, smell and taste dysfunctions, and focal neurological disorders. Results: Fifty-four children with COVID-19 were admitted and their mean age was 6.94±4.06 years. Thirty-four of them (63%) were male. The most frequent neurological manifestation was seizure (19 [45%]) followed by muscle weakness (11 [26%]), loss of consciousness (10 [23%]), and focal neurological disorders (10 [23%]). Other neurological manifestations consisted of headache (n=7), movement disorders (n=6), behavioral/personality change (n=5), ataxia (n=3), and stroke (n=3). Twenty-nine percent of our patients had leukocytosis. A neutrophil count above 70% was seen in 31% of participants. Among our patients, 81% had a positive reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2. Conclusion: During the current pandemic outbreak, hospitalized children with COVID-19 should be evaluated for neurological signs because it is common among them and should not be under-estimated.
- 1 March 2023
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 26 (3) , 166-171
Open AccessNeurologic Manifestations of Coronavirus Disease 2019 in Children: An Iranian Hospital-Based Study
Background: COVID-19 infection and its neurological manifestations were seen in children although less common than adults. The aim of this study was to determine the frequency of different types of neurologic findings of hospitalized children with COVID-19. ] Methods: This retrospective study was performed on hospitalized pediatric patients aged≤18 years with confirmed SARS-CoV-2 at Children’s Medical Center Hospital. Neurological manifestations were defined as the presence of any of the following symptoms: seizure, altered mental status, behavioral/personality change, ataxia, stroke, muscle weakness, smell and taste dysfunctions, and focal neurological disorders. Results: Fifty-four children with COVID-19 were admitted and their mean age was 6.94±4.06 years. Thirty-four of them (63%) were male. The most frequent neurological manifestation was seizure (19 [45%]) followed by muscle weakness (11 [26%]), loss of consciousness (10 [23%]), and focal neurological disorders (10 [23%]). Other neurological manifestations consisted of headache (n=7), movement disorders (n=6), behavioral/personality change (n=5), ataxia (n=3), and stroke (n=3). Twenty-nine percent of our patients had leukocytosis. A neutrophil count above 70% was seen in 31% of participants. Among our patients, 81% had a positive reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2. Conclusion: During the current pandemic outbreak, hospitalized children with COVID-19 should be evaluated for neurological signs because it is common among them and should not be under-estimated.
- 8 September 2020
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 18 (4) , 228-236
Epidemiology of HIV in Iran
Iran has been one the active countries fighting against HIV/AIDS in Middle East during last decades. Moreover, there is a strong push to strengthen the national health management system concerning HIV prevention and control. In Iran, HIV disease has its own unique features, from changes in modes of transmission to improvement in prevention programs, which can make it a good case for closer scrutiny. The present review describes the HIV epidemic in Iran from the first case diagnosed till recent progresses in diagnosis, treatment, and prevention among different groups at risk. Not only we addressed the key populations and community-based attempts to overcome HIV-related issues in clinics, but we also elaborated on the efforts and trends in society and the actual behaviors related to HIV/AIDS. Being located in the Middle East and North Africa (MENA) region, given the country-specific characteristics, despite all the national efforts along with other countries in this region, Iran still needs to take extra measures to reduce HIV transmission, especially in health education. Although Iran is one of the pioneers in implementing pertinent policies in the MENA region, including harm reduction services to reduce HIV incidence, people with substance use disorder continue to be the majority of those living with HIV in the country. Similar to other countries in this region, the HIV prevention and control programs aim at 90-90-90 targets to eliminate HIV infection and reduce the transmission, especially the mother-to-child transmission and among other key populations.
- 8 September 2020
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 18 (4) , 228-236
Epidemiology of HIV in Iran
Iran has been one the active countries fighting against HIV/AIDS in Middle East during last decades. Moreover, there is a strong push to strengthen the national health management system concerning HIV prevention and control. In Iran, HIV disease has its own unique features, from changes in modes of transmission to improvement in prevention programs, which can make it a good case for closer scrutiny. The present review describes the HIV epidemic in Iran from the first case diagnosed till recent progresses in diagnosis, treatment, and prevention among different groups at risk. Not only we addressed the key populations and community-based attempts to overcome HIV-related issues in clinics, but we also elaborated on the efforts and trends in society and the actual behaviors related to HIV/AIDS. Being located in the Middle East and North Africa (MENA) region, given the country-specific characteristics, despite all the national efforts along with other countries in this region, Iran still needs to take extra measures to reduce HIV transmission, especially in health education. Although Iran is one of the pioneers in implementing pertinent policies in the MENA region, including harm reduction services to reduce HIV incidence, people with substance use disorder continue to be the majority of those living with HIV in the country. Similar to other countries in this region, the HIV prevention and control programs aim at 90-90-90 targets to eliminate HIV infection and reduce the transmission, especially the mother-to-child transmission and among other key populations.